Pentra C400 (version 1.1.2 or lower) The ABX PENTRA 400 and 400C are discrete photometric benc...

FDA Device Recall #Z-1554-2016 — Class II — February 19, 2016

Recall Summary

Recall Number Z-1554-2016
Classification Class II — Moderate risk
Date Initiated February 19, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Horiba Instruments Inc
Location Irvine, CA
Product Type Devices
Quantity 201

Product Description

Pentra C400 (version 1.1.2 or lower) The ABX PENTRA 400 and 400C are discrete photometric bench top chemistry analyzers for clinical use. The device is intended to duplicate manual analytical procedures by performing various steps such as pipetting, mixing, heating and measuring color intensity. The device is intended for use in conjunction with certain materials to measure a variety of analytes.

Reason for Recall

Horiba Instruments, Inc. is recalling ABX Pentra 400( version 5.0.8 or lower) and Pentra C400 (version 1.1.2 or lower) because clinical chemistry analyzer malfunctions when the following certain alarms appear on the system.

Distribution Pattern

USA (nationwide Distribution) to the states of : CA, NY, AL,OK, MS, MD, NV, MN, TX, KY, WV, MI, NY, MT, IL, FL,WA, ID, MO, WY, NJ, VA, KY, GA, PA, TN, MS, KS, AZ, NE, SC, OR, OH, IA, RI, MI and NC.

Lot / Code Information

All lot/serial #s

Other Recalls from Horiba Instruments Inc

Recall # Classification Product Date
Z-1553-2016 Class II ABX Pentra 400 (version 5.0.8 or lower) The ... Feb 19, 2016
Z-0740-2016 Class II ABX PENTRA Glucose PAP CP ref. A11A01668 reage... Jan 11, 2016
Z-0742-2016 Class II ABX PENTRA Triglycerides CP ref. A11A01640 is a... Jan 11, 2016
Z-0743-2016 Class II ABX PENTRA Uric Acid CP ref. A11A01670 is an i... Jan 11, 2016
Z-0741-2016 Class II ABX PENTRA Lactic Acid CP ref. A11A01721 reage... Jan 11, 2016

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.